DVA Articles, DaVita Inc. - From 06/26/24

GE HealthCare Technologies Inc. (NASDAQ: GEHC), along with Heart Hospital of New Mexico at Lovelace Medical Center (HHNM), announced HHNM as the fi...

West Pharmaceutical Services, Inc. (NYSE: WST) is well poised for growth, backed by the robust Proprietary Products segment and sustained strength ...

McKesson Corporation's (NYSE: MCK) Biologics by McKesson, its independent specialty pharmacy specializing in oncology and rare disease areas, h...

BrainsWay Ltd. (NASDAQ: BWAY) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute ho...

In a market dealing with external shocks, value investing, or the strategy of putting money in underappreciated stocks, is fast gaining popularity....

DaVita (NYSE: DVA) recently extended the pilot phase of a previously announced supply and collaboration agreement with Nuwellis (NASDAQ: NUWE)...

DaVita (NYSE: DVA) witnessed strong momentum year to date. Shares of the company rallied 34.5% compared with 11.2% growth of the industry...

Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over d...

Disclosed on May 14, BARBARA DESOER, Director at DaVita (NYSE:DVA), executed a substantial insider sell as per the latest SEC filing. What Happened...

Koninklijke Philips (NYSE: PHG) recently announced the receipt of FDA 510(k) approval for its Zenition 30 mobile C-arm. The approval is likely to m...